Completed PHASE2 INTERVENTIONAL 2-arm NCT03812965

Botulinum Toxin in the Treatment of Gingival Smile

Effectiveness and Durability of Botulinum Toxin Application in the Treatment of Gingival Smile

Sponsor: Universidade Ibirapuera

Conditions Smiling

Updated 5 times since 2019 Last updated: Jun 4, 2019 Started: Aug 1, 2018 Primary completion: Feb 8, 2019 Completion: Apr 8, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Smiling, this trial is completed. The trial is conducted by Universidade Ibirapuera and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jul 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2019 — Jul 2019 [monthly]

Active Not Recruiting PHASE2

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Ibirapuera

Data source: Universidade Ibirapuera

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil